|
Mutation Information
|
Mutation Site
|
M184I |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
tenofovir (TDF);emtricitabine (FTC);darunavir (DRV);ritonavir;raltegravir (RAL);dolutegravir (DTG);etravirine (ETR);abacavir (ABC);lamivudine (LAM);rilpivirine (RPV);elvitegravir (EVG);Cobicistat;fosamprenavir (FPV) |
|
Country
|
USA |
Literature Information
|
PubMed PMID
|
33941212
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2021 |
|
Journal
|
AIDS research and therapy |
|
Title
|
Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced, patients living with HIV. |
|
Author
|
Rolle CP,Nguyen V,Hinestrosa F,DeJesus E |
|
Evidence
|
Historical genotypes indicated that all had an M184V/I, and 23 (59%) had an M184V/I and ≥ 1 additional NA mutation.
|
|
|
HIV Mutation Detail Information